- 4 updates
'Needless' breast cancer deaths
Hundreds of poor women in England die needlessly from breast cancer every year, experts have warned. There are around 450 avoidable deaths among women from deprived areas each year, a study suggests.
Live updates
DH: Britain targets best cancer survival rates in Europe
The Department of Health (DH) has outlined its target for Britain to have the best cancer survival rates in Europe, but the government department said early diagnosis and treatment are vital.
Early GP visits 'could make all the difference'
Women should go and see their GP at the earliest opportunity for a check-up, according to Cancer Research UK.
Experts have warned hundreds of poor women in England die needlessly from breast cancer every year.
Reacting to the new study, Dr Julie Sharp, head of health information at Cancer Research UK, said:
Advertisement
450 lives 'could be saved' each year from breast cancer
Researchers based at the Universities of Leicester and Cambridge analysed how advanced breast cancer was in over 20,000 women diagnosed between 2006-2010 using data from the National Cancer Registration Service.
They then calculated how many lives could be saved with five years of diagnosis if the stage at diagnosis for poorer women matched those of the most affluent women.
If these socio-economic differences were removed, the equivalent of around 450 lives would be saved in England every year, they said.
Hundreds of women 'needlessly die from breast cancer'
Hundreds of poor women in England die needlessly from breast cancer every year, experts have warned.
There are around 450 avoidable deaths among women from deprived areas each year, a study suggests.
The excess deaths occur because women from poorer backgrounds tend to be diagnosed with breast cancer when the disease is more advanced, the study's authors said.
The inequality between rich and poor breast cancer patients could arise because women from lower income groups are less aware of the symptoms of the disease and are more reluctant to see their GP, the authors told the National Cancer Research Institute Cancer Conference in Liverpool.